Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.
about
P1343
Pathogenesis of human immunodeficiency virus infectionCharacterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces speciesCompounds that target novel cellular components involved in HIV-1 transcriptionTopotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase IPotent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivativesIsothermal amplification using a chemical heating device for point-of-care detection of HIV-1HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTRProteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interactionModulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assayHuman immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2A block to human immunodeficiency virus type 1 assembly in murine cells.Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisOxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix proteinChromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latencyIdentification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytesTreatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.Detection of Acute HIV-1 Infection by RT-LAMP.The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1.Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovaniReactivation of latent HIV-1 provirus via targeting protein phosphatase-1.Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1HIV-1-encoded antisense RNA suppresses viral replication for a prolonged periodCasein kinase II is a selective target of HIV-1 transcriptional inhibitors.Activation and lysis of human CD4 cells latently infected with HIV-1Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1.Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latencyThe human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist.Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.
P2860
Q24634681-54E825F5-99E7-43DD-A1C7-A85AE55F4CA6Q24815984-FEBFEDAE-A9EE-44FB-9E55-AAC2497873D4Q28343602-C0827928-2B97-47A9-BCDE-9C65A0B35DD1Q28378815-386E5611-123C-4207-B9E2-5CFADF2C3864Q28378884-F64BB50D-6CBE-4859-BE8E-14D04DF723FEQ28378960-5493343F-271E-402D-8D93-455D6C14D285Q28481235-36477CD7-BF1E-4375-9D73-D7201FEA1E5FQ33292464-69FA941C-076E-4D7F-A7AD-BB9FC7740BF6Q33589167-B08053EB-118E-4BB2-812B-E2B0739A8258Q33646010-983B2E10-5C14-4B36-BE64-2ECAF95FEB79Q33783773-216ADD85-B6BA-4C92-8CBC-17E1819578A4Q33784862-C7CC17A9-3724-4385-AB62-04D0DDB767BDQ33802821-875EFB6A-2CE8-4543-A7C6-BD3B6B851262Q33883423-5BAFE75E-1E4A-4FD9-8451-21D88AF8A927Q34010283-3E13857A-CAC0-43D4-AA86-EB8297F05BE5Q34045624-70E6B42E-4C96-4895-A441-4B8A2DA1BB84Q34057748-9B5AC33C-CEFB-4706-B9BB-996F41572212Q34352092-598AD40D-7EFD-432B-A355-03FDD9FD4C62Q34362915-8B547451-5DC0-43EE-87C4-1117DAE3E8F3Q34527341-B0443EFD-2C71-45C9-96EB-81F9B402F545Q34649701-212DBD2D-684F-449A-A3EE-FDD5CBAB90D1Q35547693-382E8AA8-FC25-4239-BC6D-A4DE3D559E0DQ35628887-81A4C174-947B-4222-8E20-BB7FA7752916Q35829282-D3C2F70B-8356-4E69-94BC-D41D8B078CD3Q35829627-DE0C713C-CF5D-4351-8E9E-75ACF57587E0Q35832979-3DB425EC-27CF-457E-A600-41C9C97BB041Q35845347-66CB2E37-8CE4-453B-9E03-450D8CAF5062Q35851380-88C8B146-196E-4731-90CE-CBA0C87C6FF6Q35856911-FDDDDA80-332C-4554-8103-C77093B4BB49Q35861652-7E53FFDF-F307-478D-9A42-647283B7335DQ35882940-BD786668-6599-4B25-B50C-2DF80CD3D388Q36136773-8A011786-C89E-4136-9B3B-42FA2481570AQ36179377-EF3DCA8F-A9FC-43A8-9354-DAA20A4E0B1EQ36250921-DD147E7B-0E1F-4E84-AD85-139006F1FEFDQ36275685-939A4286-0826-47C9-9635-B1BB0F00668DQ36363411-14194B8F-C075-4B7D-A383-B269F6E0A584Q36632804-10691B65-F2B6-4636-9123-4F433E9624A8Q36669879-B5783CDB-2569-46C9-BBB9-10DC40B2BF72Q36685444-4DBD9793-AB51-4F8E-A674-50702FE2A02EQ37972644-80C6819E-CED3-401A-8675-349B47E8B324
P2860
Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Oscillation of the human immun ...... ll model of chronic infection.
@en
type
label
Oscillation of the human immun ...... ll model of chronic infection.
@en
prefLabel
Oscillation of the human immun ...... ll model of chronic infection.
@en
P2093
P2860
P1433
P1476
Oscillation of the human immun ...... ell model of chronic infection
@en
P2093
P2860
P304
P407
P4510
P577
1991-09-01T00:00:00Z